Clinical Trial Update: Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

View source ↗

Summary

An observational real-world study assessing cabozantinib as monotherapy or in combination with nivolumab for advanced or metastatic renal cell carcinoma. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Cabometyx (cabozantinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: Ipsen | Conditions: Advanced or Metastatic Renal Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING